高剂量的肝素会损害老鼠的氧化通路和血管运动
T Bachetti1, E Pasini, E Clini
1Salvatore Maugeri Foundation for Care and Research, Cardiovascular Pathophysiology Research Center, Gussago, Italy.
Circulation
|June 9, 1999
概括
高剂量的肝素减少了体内氧化 (NO) 的产生,通过降低内皮构成性NO合成酶 (ecNOS) 蛋白表达来降低血管反应能力. 这会影响血压调节.
科学领域:
- 心血管生理学心血管生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高剂量的肝素与血小板激活有关,在血栓性疾病中.
- 氨酸可能会降低内皮细胞中氧化 (NO) 的产生,影响血小板聚合.
- 肝素对NO通路和血管度的体内作用需要研究.
研究的目的:
- 为了研究高剂量肝素对氧化 (NO) 途径的体内影响.
- 为了确定肝素是否通过NO信号影响血管调节.
主要方法:
- 向麻醉的斯普雷格-道利大鼠注射高剂量的肝素.
- 通过免疫阻塞评估内皮构成NO合成酶 (ecNOS) 蛋白质含量.
- 评估了NO-依赖的血管反应和血压反应.
主要成果:
- 氨酸治疗使大动脉的ecNOS蛋白质含量减少了36% (P<0.05).
- 在肝素化大鼠中,NO依赖的血管反应受损.
- 在接受氨酸治疗的动物中,L-氨酸未能逆转系统性血管收缩.
结论:
- 高剂量的肝素在体内显著降低了ecNOS蛋白表达的调节.
- 这种下调导致血管反应能力受损,血压调节发生改变.
相关概念视频
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...


